AN ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH IDIOPATHIC HEART-FAILURE

被引:18
|
作者
ANDERSSON, B
CAIDAHL, K
WAAGSTEIN, F
机构
[1] SAHLGRENS UNIV HOSP,WALLENBERG LAB CARDIOVASC RES,S-41345 GOTHENBURG,SWEDEN
[2] SAHLGRENS UNIV HOSP,DIV CARDIOL,S-41345 GOTHENBURG,SWEDEN
[3] SAHLGRENS UNIV HOSP,DIV CLIN PHYSIOL,S-41345 GOTHENBURG,SWEDEN
关键词
CONGESTIVE HEART FAILURE; DILATED CARDIOMYOPATHY; DIASTOLIC FUNCTION; ECHOCARDIOGRAPHY; EPIDEMIOLOGY; VENTRICULAR FUNCTION;
D O I
10.1378/chest.107.3.680
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The primary myocardial disease idiopathic dilated cardiomyopathy (IDCM) is not clearly defined in the literature. The description is both morphologic and etiologic. We examined consecutive patients with congestive heart failure (CHF) of unknown cause to identify possible cases of IDCM and to give a detailed description of echocardiographic data and possible diastolic dysfunction in this group. The hospital records of patients aged 16 to 65 years hospitalized due to CHF or IDCM during a 6-year period (N=2,711) were evaluated in a defined region of western Sweden. Twenty-two percent (584/2,711) of these records contained no plausible cause of CHF or IDCM, and among patients being alive, obvious cause was lacking in 411 of 1,516 (27%). These 411 patients were offered a diagnostic investigation, including echocardiography, and they were compared with a randomly selected control group (n=103) from the general population. Of 411 patients, 293 accepted investigation. From the control group, we defined the reference level for left ventricular (LV) dilatation to be >32 mm/m(2), and reduced ejection fraction according to Teichholz formula to be <50%. Applying these borderlines, we identified LV dilatation and systolic dysfunction to be present in 30%, either dilatation or systolic dysfunction in 36%, and neither in 34%. In patients without any signs of systolic dysfunction 44% (26/59) showed signs of diastolic dysfunction. In a multivariate analysis, LV dimension was not independently correlated to disease, although LV dimension was univariately correlated to ejection fraction (EF) (r=-0.59; p<0.0001). However, EF (p<0.0001),left atrial dimension (p<0.0001), and the first third filling fraction (p<0.0001) were the constellation of parameters that most accurately separated patients from controls. By using these three parameters, a positive and negative predictive accuracy of 98% and 61%, respectively, was achieved. Thus, in a consecutive group of patients with idiopathic CHF recruited from a nonselectcd group of hospitalized patients with CHF, all grades of ventricular unction were found. In this group, 30% were identified as having IDCM. We give reference values for the diagnosis of idiopathic IDCM and a simple tool to identify patients with systolic and diastolic dysfunction.
引用
收藏
页码:680 / 689
页数:10
相关论文
共 50 条
  • [41] COMPLIANCE IN HYPERTENSIVES AND HEART-FAILURE PATIENTS
    LUSCHER, T
    TUMA, J
    SCHEU, H
    HAASE, W
    TENSCHERT, W
    AMMANN, D
    VOLLM, K
    VETTER, W
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 111 (52) : 2047 - 2050
  • [42] CARDIAC REHABILITATION FOR HEART-FAILURE PATIENTS
    DUBACH, P
    FROELICHER, VF
    CARDIOLOGY, 1989, 76 (05) : 368 - 373
  • [43] ARRHYTHMIAS AND THEIR TREATMENT IN PATIENTS WITH HEART-FAILURE
    REHNQVIST, N
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (20): : J61 - J64
  • [44] SAFETY OF ENOXIMONE IN PATIENTS WITH HEART-FAILURE
    GILFRICH, HJ
    DIETERICH, HA
    ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 : 93 - 97
  • [45] CAPTOPRIL IN ELDERLY PATIENTS WITH HEART-FAILURE
    MURPHY, PJ
    VANDERCAMMEN, T
    MALONELEE, J
    BRITISH MEDICAL JOURNAL, 1986, 293 (6541): : 239 - 240
  • [46] PHARMACOKINETICS OF FUROSEMIDE IN PATIENTS WITH HEART-FAILURE
    TILSTONE, WJ
    LAWSON, DH
    CLINICAL RESEARCH, 1976, 24 (03): : A513 - A513
  • [47] CAPTOPRIL IN ELDERLY PATIENTS WITH HEART-FAILURE
    HOSIE, J
    HOSIE, G
    BRITISH MEDICAL JOURNAL, 1986, 293 (6549): : 761 - 761
  • [48] PERIODIC RESPIRATION IN PATIENTS WITH HEART-FAILURE
    ANDREAS, S
    VONBRESKA, B
    KOPP, E
    FIGULLA, HR
    KREUZER, H
    CLINICAL INVESTIGATOR, 1993, 71 (04): : 281 - 285
  • [49] CONTEMPORARY MANAGEMENT OF PATIENTS WITH HEART-FAILURE
    YOUNG, JB
    MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (05) : 1171 - +
  • [50] IS ASPIRIN SAFE FOR PATIENTS WITH HEART-FAILURE
    CLELAND, JGF
    BULPITT, CJ
    FALK, RH
    FINDLAY, IN
    OAKLEY, CM
    MURRAY, G
    POOLEWILSON, PA
    PRENTICE, CRM
    SUTTON, GC
    BRITISH HEART JOURNAL, 1995, 74 (03): : 215 - 219